Dr. Tanvir Bajwa Discusses the Effectiveness of the Evolut FX Transcatheter Aortic Valve System
By Rob Dillard, Dr. Tanvir Bajwa - Last Updated: May 19, 2023The next generation supra-annular, self-expanding Evolut FX TAVR system (Medtronic) has been designed to improve ease of use in coronary access through enhanced deliverability and trackability. Its improvements were assessed via a physician survey analysis, and the findings were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.
Advertisement
In this exclusive interview, DocWire News spoke with lead researcher Dr. Tanvir K. Bajwa about the FX system procedural outcomes following design enhancements.
Advertisement
Related Posts
Dr. Daniel Judge discusses how the ATTRibute-CM trial marks a turning point in ATTR cardiomyopathy treatment and research.
Elevated [Lp(a)] is strongly associated with an increased risk of atherosclerotic cardiovascular disease.
A study compared the effects of Mat Pilates on various cardiometabolic risk factors in women who had gone through menopause.
The FDA approved the use of Edwards Lifesciences' SAPIEN 3 TAVR platform for patients with severe aortic stenosis.
Women with maternal hypertension who birth preterm infants incur a risk for that child having adverse neurodevelopment.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.